{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T01:50:43Z","timestamp":1782697843183,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009157","name":"U.S. Department of Health & Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research","doi-asserted-by":"publisher","award":["90SI5012"],"award-info":[{"award-number":["90SI5012"]}],"id":[{"id":"10.13039\/100009157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41393-020-0431-9","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T12:02:50Z","timestamp":1581595370000},"page":"921-929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study"],"prefix":"10.1038","volume":"58","author":[{"given":"Christina V.","family":"Oleson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-4113","authenticated-orcid":false,"given":"Ralph J.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Formal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Modlesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin E.","family":"Leiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"431_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jor.1100100309","volume":"10","author":"DE Garland","year":"1992","unstructured":"Garland DE, Stewart CA, Adkins RH, Hu SS, Rosen C, Liotta FJ, et al. Osteoporosis after spinal cord injury. J Orthop Res. 1992;10:371\u20138.","journal-title":"J Orthop Res"},{"key":"431_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.sc.3100905","volume":"38","author":"P Frey-Rindova","year":"2000","unstructured":"Frey-Rindova P, de Bruin ED, St\u00fcssi E, Dambacher MA, Dietz V. Bone mineral density in upper and lower extremities during 12 months after spinal cord injury measured by peripheral quantitative computed tomography. Spinal Cord. 2000;38:26\u201332.","journal-title":"Spinal Cord."},{"key":"431_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF02441186","volume":"27","author":"A Chantraine","year":"1979","unstructured":"Chantraine A, Heynen G, Franchimont P. Bone metabolism, parathyroid hormone, and calcitonin in paraplegia. Calcif Tissue Int. 1979;27:199\u2013204.","journal-title":"Calcif Tissue Int"},{"key":"431_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF02547214","volume":"17","author":"P Minaire","year":"1974","unstructured":"Minaire P, Neunier P, Edouard C, Bernard J, Courpron P, Bourret J. Quantitative histological data on disuse osteoporosis: comparison with biological data. Calcif Tissue Res. 1974;17:57\u201373.","journal-title":"Calcif Tissue Res"},{"key":"431_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1310\/sci1404-1","volume":"14","author":"BC Craven","year":"2009","unstructured":"Craven BC, Robertson LA, McGillivray CF, Adachi JD. Detection and treatment of sublesional osteoporosis among patients with chronic spinal cord injury: proposed paradigms. Top Spinal Cord Inj Rehabil. 2009;14:1\u201322.","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"431_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2362.1990.tb01865.x","volume":"20","author":"F Biering-Sorensen","year":"1990","unstructured":"Biering-Sorensen F, Bohr HH, Schaadt OP. Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Investig. 1990;20:330\u20135.","journal-title":"Eur J Clin Investig"},{"key":"431_CR7","first-page":"235","volume":"296","author":"JE Dunford","year":"2001","unstructured":"Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharm Exp Ther. 2001;296:235\u201342.","journal-title":"J Pharm Exp Ther"},{"key":"431_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","volume":"15","author":"FP Coxon","year":"2000","unstructured":"Coxon FP, Helfrich MH, Van\u2019t Hof R, Sebti S, Ralston SH, Hamilton A, et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Min Res. 2000;15:1467\u201376.","journal-title":"J Bone Min Res"},{"key":"431_CR9","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Peiper CP, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N. Engl J Med. 2007;357:1799\u2013809.","journal-title":"N. Engl J Med"},{"key":"431_CR10","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.bone.2007.01.016","volume":"40","author":"K Saag","year":"2007","unstructured":"Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density. Bone. 2007;40:1238\u201343.","journal-title":"Bone."},{"key":"431_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","volume":"80","author":"J Shapiro","year":"2007","unstructured":"Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, BrintzenhofeSzoc K, et al. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int. 2007;80:316\u201322.","journal-title":"Calcif Tissue Int"},{"key":"431_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","volume":"22","author":"JS Bubbear","year":"2011","unstructured":"Bubbear JS, Gall A, Middleton FR, Ferguson-Pell M, Swaminathan R, Keen RW. Early treatment with zoledronic acid prevents bone loss at the hip following spinal cord injury. Osteoporos Int. 2011;22:271\u20139.","journal-title":"Osteoporos Int."},{"key":"431_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00774-014-0602-x","volume":"33","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cirnigliaro CM, La Fountaine MF, Martinez L, Kirshblum SC, Spungen AM. Zoledronic acid administration failed to prevent bone loss at the knee in person with acute spinal cord injury an observational cohort study. J Bone Min Metab. 2015;33:410\u201321.","journal-title":"J Bone Min Metab"},{"key":"431_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.apmr.2004.09.006","volume":"86","author":"P Eser","year":"2005","unstructured":"Eser P, Frotzler A, Zehnder Y, Denoth J. Fracture threshold in the femur and tibia of people with spinal cord injury as determined by peripheral quantitative computed tomography. Arch Phys Med Rehabil. 2005;86:498\u2013504.","journal-title":"Arch Phys Med Rehabil"},{"key":"431_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41393-018-0195-7","volume":"56","author":"S Goenka","year":"2018","unstructured":"Goenka S, Sethi S, Panday N, Joshi M, Jindal R. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial. Spinal Cord. 2018;56:1207\u201311.","journal-title":"Spinal Cord."},{"key":"431_CR16","first-page":"833","volume":"8","author":"TJ Schnitzer","year":"2016","unstructured":"Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D. Zoledronic acid treatment after acute spinal cord injury: results of a randomized, placebo-controlled pilot trial. Phys Med Rehabil. 2016;8:833\u201343.","journal-title":"Phys Med Rehabil"},{"key":"431_CR17","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.apmr.2005.06.001","volume":"86","author":"RK Shields","year":"2005","unstructured":"Shields RK, Schlechte J, Dudley-Javoroski S, Zwart BD, Clark SD, Grant SA, et al. Bone mineral density after spinal cord injury: a reliable method for knee measurement. Arch Phys Med Rehabil. 2005;86:1969\u201373.","journal-title":"Arch Phys Med Rehabil"},{"key":"431_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","volume":"561","author":"Y Ikebuchi","year":"2018","unstructured":"Ikebuchi Y, Aoki S, Honma M, Hayashi M, Sugamori Y, Khan M, et al. Coupling of bone resorption and formation by RANKL reverse signaling. Nature. 2018;561:195\u2013200.","journal-title":"Nature."},{"key":"431_CR19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.apmr.2016.02.012","volume":"97","author":"KC Kirshblum","year":"2016","unstructured":"Kirshblum KC, Botticello AL, Dyston-Hudson TA, Byrne R, Marino RJ, Lammertse DP. Patterns of sacral sparing components on neurologic recovery in newly injured persons with traumatic spinal cord injury. Arch Phys Med Rehabil. 2016;97:1647\u201355.","journal-title":"Arch Phys Med Rehabil"},{"key":"431_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41393-019-0299-8","volume":"57","author":"AA Aimetti","year":"2019","unstructured":"Aimetti AA, Kirshblum S, Curt A, Mobley J, Grossman RG, Guest JD. Natural history of neurological improvement following complete (AIS A) thoracic spinal cord injury across three registries to guide acute clinical trial design and interpretation. Spinal Cord. 2019;57:753\u201362.","journal-title":"Spinal Cord."},{"key":"431_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00586-006-0163-3","volume":"16","author":"AL Reiter","year":"2007","unstructured":"Reiter AL, Volk A, Vollmar J, Fromm B, Gerner HJ. Changes of basic bone turnover parameters in short-term and long-term patients with spinal cord injury. Eur Spine J. 2007;16:771\u20136.","journal-title":"Eur Spine J"},{"key":"431_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1047-9651(18)30150-5","volume":"11","author":"WA Bauman","year":"2000","unstructured":"Bauman WA, Spungen AM. Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin N Am. 2000;11:109\u201340.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"431_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/10790268.1997.11719458","volume":"20","author":"JH Frisbie","year":"1997","unstructured":"Frisbie JH. Fractures after myelopathy: the risk quantified. J Spinal Cord Med. 1997;20:66\u201369.","journal-title":"J Spinal Cord Med"},{"key":"431_CR24","first-page":"415","volume":"83","author":"D Roberts","year":"1998","unstructured":"Roberts D, Lee W, Cuneo RC, Wittmann J, Ward G, Flatman R, et al. Longitudinal study of bone turnover after acute spinal cord injury. J Clin Endocrinol Metab. 1998;83:415\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR25","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.apmr.2007.08.004","volume":"88","author":"AL Davies","year":"2007","unstructured":"Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil. 2007;88:1384\u201393.","journal-title":"Arch Phys Med Rehabil"},{"key":"431_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/10790268.2004.11753748","volume":"27","author":"DE Garland","year":"2004","unstructured":"Garland DE, Adkins RH, Kushwaha V, Stewart C. Risk factors for osteoporosis at the knee in the spinal cord injury population. J Spinal Cord Med. 2004;27:202\u20136.","journal-title":"J Spinal Cord Med"},{"key":"431_CR27","first-page":"204","volume":"30","author":"P Pietschmann","year":"1992","unstructured":"Pietschmann P, Pils P, Woloszczik W, Maerk R, Lessan D, Stipicic J. Increased serum osteocalcin levels in patients with paraplegia. Paraplegia. 1992;30:204\u20139.","journal-title":"Paraplegia."},{"key":"431_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S8756-3282(00)00326-4","volume":"27","author":"M Dauty","year":"2000","unstructured":"Dauty M, Perrouin VB, Maugars Y, Dubois C, Mathe JF. Supralesional and sublesional bone mineral density in spinal cord injured patients. Bone. 2000;27:305\u20139.","journal-title":"Bone."},{"key":"431_CR29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00198-013-2557-5","volume":"25","author":"WB Edwards","year":"2014","unstructured":"Edwards WB, Schnitzer TJ, Troy KL. Bone mineral stiffness loss at the distal femur and proximal tibia in acute spinal cord injury. Osteoporos Int. 2014;25:1005\u201315.","journal-title":"Osteoporos Int."}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0431-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0431-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0431-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:39:00Z","timestamp":1684618740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-020-0431-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1038\/s41393-020-0431-9","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"12 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}